Changes in Circulating Biomarkers in Patients With Ischemic Heart Failure After Treatment With Autologous Mesenchymal Stromal Cells and c-Kit-Positive Cardiac Cells, Alone or in Combination: Results From the Cardiovascular Cell Therapy Research Network CONCERT-HF Clinical Trial.

Saved in:
Bibliographic Details
Title: Changes in Circulating Biomarkers in Patients With Ischemic Heart Failure After Treatment With Autologous Mesenchymal Stromal Cells and c-Kit-Positive Cardiac Cells, Alone or in Combination: Results From the Cardiovascular Cell Therapy Research Network CONCERT-HF Clinical Trial.
Authors: Chacon-Alberty L; Texas Heart Institute at Baylor College of Medicine Houston TX USA., Tan X; Department of Statistics Rice University Houston TX USA., Li M; Department of Statistics Rice University Houston TX USA., Tang XL; School of Medicine University of Louisville Louisville KY USA., Hochman-Mendez C; Department of Surgery Texas Heart Institute at Baylor College of Medicine Houston TX USA.; Biofluids Repository Core, Advanced Technology Core, Baylor College of Medicine Houston TX USA., Bolli R; School of Medicine University of Louisville Louisville KY USA.
Source: Journal of the American Heart Association [J Am Heart Assoc] 2026 May 05; Vol. 15 (9), pp. e045963. Date of Electronic Publication: 2026 Apr 20.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2047-9980
DOI:10.1161/JAHA.125.045963